Life Sciences/Biotech

Perrigo Acquires Mexican OTC Manufacturer For $25 Million

ALLEGAN - Perrigo Company announced Monday that it has acquired Laboratorios Diba, S.A. for approximately $25 million in cash. Based in Guadalajara, Mexico, privately-held Laboratorios Diba is a store brand manufacturer of over-the-counter and prescription pharmaceuticals, including antibiotics, hormonals and opthalmics. The acquisition is expected to add nearly $15 million of annual sales. "Perrigo has

By |2008-10-06T00:00:00-04:00October 6th, 2008|Archive, Life Sciences/Biotech|

First Anti Stem Cell R&D Ads Hit The Airwaves

LANSING - The first ad on November ballot proposals hit the airwaves Tuesday with opponents of Proposal 2008-2 arguing the plan to allow embryonic stem cell research in the state will mean more costs to taxpayers. If the election were held Tuesday, a majority of voters would support a proposal expanding the use of embryonic

By |2008-09-23T00:00:00-04:00September 23rd, 2008|Archive, Life Sciences/Biotech|

Van Andel Institute Research Find Drug Target For Heart, Blood Diseases

GRAND RAPIDS - Van Andel Institute researchers have determined the molecular structure of a nuclear receptor, which regulates the expression of specific genes within cells, which may serve as a drug target for diseases related to heart and blood vessel development, human embryonic development and female infertility. Researchers also found that the receptor, named COUP-TFII,

By |2008-09-16T00:00:00-04:00September 16th, 2008|Archive, Life Sciences/Biotech|

Wayne State Grad To Receive da Vinci Lifetime Achievement Award

SOUTHFIELD - Jeffery Kocsis has been named to receive the da Vinci Lifetime Achievement Award from the National Multiple Sclerosis Society, Michigan Chapter for his work with new treatment strategies for people with MS. Kocsis received his Ph.D. in 1976 from Wayne State University and has a long history of research and publications on transplantation-based

By |2008-09-03T00:00:00-04:00September 3rd, 2008|Archive, Life Sciences/Biotech|

Karmanos Cancer Center Lands $4.7 Million Army Medical Research Grant

DETROIT �?? The Barbara Ann Karmanos Cancer Institute�??s National Oncogenomics and Molecular Imaging Center will soon get a $4,672,000 in federal appropriations from the U.S. Army to help develop technology that will allow for the diagnosis of human cancer by defining oncogene signatures that characterize cancers in individual patients. The federal funding, which will be

By |2008-08-22T00:00:00-04:00August 22nd, 2008|Archive, Life Sciences/Biotech|

New Discovery May Improve Effectiveness Of Cancer Therapies

GRAND RAPIDS - Researchers at Van Andel Institute and Novartis Institutes for Biomedical Research have identified an important enzyme required for cancer cell survival, which could help lead to more effective treatment of pancreatic, prostate and lung cancers. Lowering levels of the enzyme caused a wide variety of cancer cells to die, reduced proliferation of

By |2008-08-19T00:00:00-04:00August 19th, 2008|Archive, Life Sciences/Biotech|

The Michigan Life Sciences Pipeline Adds More Website Resources

TROY - CJPS Enterprises, the operator of the Michigan Life Sciences Pipeline, announced it has posted online more resources for Michigan companies looking for assistance to enter the healthcare market, or to grow their existing healthcare business. This project is dedicated to providing users with information regarding the life sciences. A number of helpful resources,

By |2008-08-18T00:00:00-04:00August 18th, 2008|Archive, Life Sciences/Biotech|

MichBio To Offer Bi-Annual Magazine To Highlight

ANN ARBOR ? Biotech trade association MichBio will publish a bi-annual magazine starting in November devoted to chronicling the discoveries, trends, issues and personalities that are shaping Michigan's biosciences community. "An important part of MichBio's mission is to support our members and the industry as a whole by disseminating materials that inform, educate and assist

By |2008-08-18T00:00:00-04:00August 18th, 2008|Archive, Life Sciences/Biotech|

Embryonic Stem Cell Research Bill Not Change Other State Prohibitions

LANSING - The Michigan Board of State Canvassers was urged by opponents of embryonic stem cell research to point out on ballot language that proposal would effectively allow for a market in embryos and cut state government out of any regulations on embryonic research, while supporters said the proposal is narrowly written to limit the

By |2008-08-12T00:00:00-04:00August 12th, 2008|Archive, Life Sciences/Biotech|